<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02622295</url>
  </required_header>
  <id_info>
    <org_study_id>200412709</org_study_id>
    <secondary_id>R01HD084645</secondary_id>
    <nct_id>NCT02622295</nct_id>
  </id_info>
  <brief_title>Musculoskeletal Plasticity After Spinal Cord Injury</brief_title>
  <official_title>Musculoskeletal Plasticity After Spinal Cord Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Richard K Shields</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Iowa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with spinal cord injury (SCI) experience metabolic syndrome, diabetes, obesity,
      pressure ulcers, and cardiovascular disease at far greater rates than the general population.
      A rehabilitation method to prevent or reverse the systemic metabolic consequences of SCI is a
      pressing need. The purpose of this study is to determine the dose of muscle activity that can
      enhance an oxidative muscle phenotype and improve clinical markers of metabolic health and
      bone turnover in patients with SCI. The long-term goal of this research is to develop
      exercise-based interventions to prevent secondary health conditions such as diabetes and to
      ultimately protect health-related quality of life (QOL). Specific Aim 1: To compare changes
      in skeletal muscle gene regulation in individuals who receive high frequency (HF)
      active-resisted stance and low frequency (LF) active-resisted stance for 16 weeks. Hypothesis
      1: The expression of genes regulating skeletal muscle metabolism will support that HF and LF
      both instigate a shift toward an oxidative muscle phenotype. A novel finding will be that LF
      is a powerful regulator of oxidative pathways in skeletal muscle. Specific Aim 2: To compare
      changes in systemic markers of metabolic health and bone turnover in individuals with SCI who
      receive HF or LF for 16 weeks. Hypothesis 2: HF and LF will both reduce glucose/insulin
      levels and HOMA (homeostasis model assessment) score. However, only HF will demonstrate an
      effect on bone turnover (higher serum levels of osteocalcin). Secondary Aim: To measure
      subject-reported QOL using the EQ-5D survey metric. Hypothesis 3: HF and LF subjects will
      show a trend toward improved self-reported QOL after 16 weeks. There will be an association
      between metabolic improvement and improved perception of QOL. These observations will support
      that this intervention has strong feasibility for future clinical translation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 2015</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Acute gene regulation: MSTN</measure>
    <time_frame>3 hours</time_frame>
    <description>Acute post-stimulation effect upon skeletal muscle myostatin (MSTN) expression, measured via muscle biopsy and exon array analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Acute gene regulation: PGC1-alpha</measure>
    <time_frame>3 hours</time_frame>
    <description>Acute post-stimulation effect upon skeletal muscle peroxisome proliferator-activated receptor gamma coactivator alpha (PGC1-alpha) expression, measured via muscle biopsy and exon array analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Acute gene regulation: PDK4</measure>
    <time_frame>3 hours</time_frame>
    <description>Acute post-stimulation effect upon skeletal muscle pyruvate dehydrogenase kinase, isozyme 4 (PDK4-alpha) expression, measured via muscle biopsy and exon array analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Acute gene regulation: SDHB</measure>
    <time_frame>3 hours</time_frame>
    <description>Acute post-stimulation effect upon skeletal muscle succinate dehydrogenase-B (SDHB) expression, measured via muscle biopsy and exon array analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-training gene regulation: MSTN</measure>
    <time_frame>16 weeks</time_frame>
    <description>Change from baseline in skeletal muscle myostatin (MSTN) expression, measured via muscle biopsy and exon array analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-training gene regulation: PGC1-alpha</measure>
    <time_frame>16 weeks</time_frame>
    <description>Change from baseline in skeletal muscle peroxisome proliferator-activated receptor gamma coactivator alpha (PGC1-alpha) expression, measured via muscle biopsy and exon array analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-training gene regulation: PDK4</measure>
    <time_frame>16 weeks</time_frame>
    <description>Change from baseline in skeletal muscle pyruvate dehydrogenase kinase, isozyme 4 (PDK4-alpha) expression, measured via muscle biopsy and exon array analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-training gene regulation: SDHB</measure>
    <time_frame>16 weeks</time_frame>
    <description>Change from baseline in skeletal muscle succinate dehydrogenase-B (SDHB) expression, measured via muscle biopsy and exon array analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-training metabolism: fasting glucose</measure>
    <time_frame>16 weeks</time_frame>
    <description>Change from baseline in fasting glucose, measured via venipuncture and standard laboratory assays</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-training metabolism: fasting insulin</measure>
    <time_frame>16 weeks</time_frame>
    <description>Change from baseline in fasting insulin, measured via venipuncture and standard laboratory assays</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-training metabolism: HOMA score</measure>
    <time_frame>16 weeks</time_frame>
    <description>Change from baseline in HOMA score, calculated via the Homeostasis Model Assessement equation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-training bone turnover: osteocalcin</measure>
    <time_frame>16 weeks</time_frame>
    <description>Change from baseline in serum osteocalcin, measured via venipuncture and enzyme-linked immunosorbent assay</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-training subject-report measures: EQ-5D</measure>
    <time_frame>16 weeks</time_frame>
    <description>Change from baseline in QALY (quality-adjusted life-years) via the EQ-5D subject-report survey instrument</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Spinal Cord Injuries</condition>
  <arm_group>
    <arm_group_label>Acute gene regulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adaptations in gene regulation in response to single-session high-frequency active-resisted stance or single-session low-frequency active-resisted stance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>16 Week Training Study</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adaptations in gene regulation, metabolic markers, and subject-report metrics in response to 16 weeks of high-frequency active-resisted stance training or 16 weeks of low-frequency active-resisted stance training</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Single-session high-frequency active-resisted stance</intervention_name>
    <description>In a standing frame or standing wheelchair, the quadriceps and hamstrings will be electrically activated to elicit high muscle forces.</description>
    <arm_group_label>Acute gene regulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Single-session low-frequency active-resisted stance</intervention_name>
    <description>In a standing frame or standing wheelchair, the quadriceps and hamstrings will be electrically activated to elicit low muscle forces.</description>
    <arm_group_label>Acute gene regulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>High-frequency active-resisted stance training</intervention_name>
    <description>In a standing frame or standing wheelchair, the quadriceps and hamstrings will be electrically activated to elicit high muscle forces. Subjects will train for 16 weeks.</description>
    <arm_group_label>16 Week Training Study</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Low-frequency active-resisted stance training</intervention_name>
    <description>In a standing frame or standing wheelchair, the quadriceps and hamstrings will be electrically activated to elicit low muscle forces. Subjects will train for 16 weeks.</description>
    <arm_group_label>16 Week Training Study</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Motor complete SCI (AIS A-B)

        Exclusion Criteria:

          1. Pressure ulcers

          2. Chronic infection

          3. Lower extremity muscle contractures

          4. Deep vein thrombosis

          5. Bleeding disorder

          6. Recent limb fractures

          7. Any comorbid disease known to affect bone metabolism (such as parathyroid dysfunction)

          8. Pregnancy

          9. Anti-osteoporosis medications

         10. Vitamin D supplements

         11. Metformin or other medications for diabetes.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard K Shields, PhD, PT</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Iowa</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Richard K Shields, PhD, PT</last_name>
    <phone>319-335-9791</phone>
    <email>richard-shields@uiowa.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shauna Dudley-Javoroski, PhD, PT</last_name>
    <phone>319-356-8203</phone>
    <email>shauna-dudley@uiowa.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Dudley-Javoroski S, Saha PK, Liang G, Li C, Gao Z, Shields RK. High dose compressive loads attenuate bone mineral loss in humans with spinal cord injury. Osteoporos Int. 2012 Sep;23(9):2335-46. doi: 10.1007/s00198-011-1879-4. Epub 2011 Dec 21.</citation>
    <PMID>22187008</PMID>
  </reference>
  <reference>
    <citation>Dudley-Javoroski S, Shields RK. Dose estimation and surveillance of mechanical loading interventions for bone loss after spinal cord injury. Phys Ther. 2008 Mar;88(3):387-96. doi: 10.2522/ptj.20070224. Epub 2008 Jan 17.</citation>
    <PMID>18202080</PMID>
  </reference>
  <reference>
    <citation>Dudley-Javoroski S, Shields RK. Active-resisted stance modulates regional bone mineral density in humans with spinal cord injury. J Spinal Cord Med. 2013 May;36(3):191-9. doi: 10.1179/2045772313Y.0000000092.</citation>
    <PMID>23809588</PMID>
  </reference>
  <reference>
    <citation>Dudley-Javoroski S, Littmann AE, Iguchi M, Shields RK. Doublet stimulation protocol to minimize musculoskeletal stress during paralyzed quadriceps muscle testing. J Appl Physiol (1985). 2008 Jun;104(6):1574-82. doi: 10.1152/japplphysiol.00892.2007. Epub 2008 Apr 24.</citation>
    <PMID>18436697</PMID>
  </reference>
  <reference>
    <citation>Dudley-Javoroski S, Shields RK. Assessment of physical function and secondary complications after complete spinal cord injury. Disabil Rehabil. 2006 Jan 30;28(2):103-10.</citation>
    <PMID>16393840</PMID>
  </reference>
  <reference>
    <citation>Adams CM, Suneja M, Dudley-Javoroski S, Shields RK. Altered mRNA expression after long-term soleus electrical stimulation training in humans with paralysis. Muscle Nerve. 2011 Jan;43(1):65-75. doi: 10.1002/mus.21831.</citation>
    <PMID>21171097</PMID>
  </reference>
  <reference>
    <citation>Frey Law LA, Shields RK. Femoral loads during passive, active, and active-resistive stance after spinal cord injury: a mathematical model. Clin Biomech (Bristol, Avon). 2004 Mar;19(3):313-21.</citation>
    <PMID>15003348</PMID>
  </reference>
  <reference>
    <citation>Kunkel SD, Suneja M, Ebert SM, Bongers KS, Fox DK, Malmberg SE, Alipour F, Shields RK, Adams CM. mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass. Cell Metab. 2011 Jun 8;13(6):627-38. doi: 10.1016/j.cmet.2011.03.020.</citation>
    <PMID>21641545</PMID>
  </reference>
  <reference>
    <citation>McHenry CL, Wu J, Shields RK. Potential regenerative rehabilitation technology: implications of mechanical stimuli to tissue health. BMC Res Notes. 2014 Jun 3;7:334. doi: 10.1186/1756-0500-7-334.</citation>
    <PMID>24894666</PMID>
  </reference>
  <reference>
    <citation>McHenry CL, Shields RK. A biomechanical analysis of exercise in standing, supine, and seated positions: Implications for individuals with spinal cord injury. J Spinal Cord Med. 2012 May;35(3):140-7. doi: 10.1179/2045772312Y.0000000011.</citation>
    <PMID>22507023</PMID>
  </reference>
  <reference>
    <citation>Petrie MA, Suneja M, Faidley E, Shields RK. A minimal dose of electrically induced muscle activity regulates distinct gene signaling pathways in humans with spinal cord injury. PLoS One. 2014 Dec 22;9(12):e115791. doi: 10.1371/journal.pone.0115791. eCollection 2014.</citation>
    <PMID>25531450</PMID>
  </reference>
  <reference>
    <citation>Petrie MA, Suneja M, Faidley E, Shields RK. Low force contractions induce fatigue consistent with muscle mRNA expression in people with spinal cord injury. Physiol Rep. 2014 Feb 25;2(2):e00248. doi: 10.1002/phy2.248. eCollection 2014 Feb 1.</citation>
    <PMID>24744911</PMID>
  </reference>
  <reference>
    <citation>Shields RK, Dudley-Javoroski S. Monitoring standing wheelchair use after spinal cord injury: a case report. Disabil Rehabil. 2005 Feb 4;27(3):142-6.</citation>
    <PMID>15823996</PMID>
  </reference>
  <reference>
    <citation>Petrie M, Suneja M, Shields RK. Low-frequency stimulation regulates metabolic gene expression in paralyzed muscle. J Appl Physiol (1985). 2015 Mar 15;118(6):723-31. doi: 10.1152/japplphysiol.00628.2014. Epub 2015 Jan 29.</citation>
    <PMID>25635001</PMID>
  </reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 2, 2015</study_first_submitted>
  <study_first_submitted_qc>December 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2015</study_first_posted>
  <last_update_submitted>November 27, 2017</last_update_submitted>
  <last_update_submitted_qc>November 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 29, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Iowa</investigator_affiliation>
    <investigator_full_name>Richard K Shields</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>metabolism</keyword>
  <keyword>glucose</keyword>
  <keyword>osteoporosis</keyword>
  <keyword>secondary health conditions</keyword>
  <keyword>quality of life</keyword>
  <keyword>standing</keyword>
  <keyword>electrical stimulation</keyword>
  <keyword>diabetes</keyword>
  <keyword>insulin</keyword>
  <keyword>skeletal muscle</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Spinal Cord Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

